📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

AAV2/8 Anti-angiogenic Gene Therapy Using Single-Chain Antibodies Inhibits Murine Choroidal Neovascularization. (2019)

First Author: Hughes CP

Attributed to: Developing gene therapy to treat blindness caused by Stargardt Disease funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/j.omtm.2018.11.005

PubMed Identifier: 30719487

Publication URI: http://europepmc.org/abstract/MED/30719487

Type: Journal Article/Review

Volume: 13

Parent Publication: Molecular therapy. Methods & clinical development

ISSN: 2329-0501